muscular atrophies
http://www.yso.fi/onto/yso/p15977
Related publications and other outputs
- Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting (2021) Nissinen, Tuuli A.; et al.; A1; OA
- Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer patients : A secondary analysis of two randomized controlled trials (2021) Newton, Robert U.; et al.; A1; OA
- Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments (2021) Hulmi, Juha J.; et al.; A2; OA
- Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation (2020) Cisterna, Bruno A.; et al.; A1; OA
- Muscle and bone mass in middle‐aged women : role of menopausal status and physical activity (2020) Sipilä, Sarianna; et al.; A1; OA
- Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia : the effects of blocking myostatin and activins (2020) Hulmi, J.; et al.; A1; OA
- Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver (2019) Hentilä, Jaakko; et al.; A1; OA
- Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota : A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia? (2019) Pekkala, Satu; et al.; A1; OA
- Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations (2019) Ballarò, Riccardo; et al.; A1
- Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade (2019) Lautaoja, Juulia; et al.; A1; OA